Table of Contents
International Journal of Peptides
Volume 2012, Article ID 637212, 5 pages
http://dx.doi.org/10.1155/2012/637212
Research Article

Pan-PPAR Agonist, Bezafibrate, Restores Angiogenesis in Hindlimb Ischemia in Normal and Diabetic Rats

1Department of Physiology, Isfahan University of Medical Sciences, Hezar Jarib Ave, Isfahan, Iran
2Department of Anatomy, Isfahan University of Medical Sciences, Isfahan, Iran

Received 4 February 2012; Accepted 16 April 2012

Academic Editor: Ayman El-Faham

Copyright © 2012 M. Khazaei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Desvergne and W. Wahli, “Peroxisome proliferator-activated receptors: nuclear control of metabolism,” Endocrine Reviews, vol. 20, no. 5, pp. 649–688, 1999. View at Google Scholar · View at Scopus
  2. T. M. Willson, P. J. Brown, D. D. Sternbach, and B. R. Henke, “The PPARs: from orphan receptors to drug discovery,” Journal of Medicinal Chemistry, vol. 43, no. 4, pp. 527–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Tenenbaum, M. Motro, and E. Z. Fisman, “Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons,” Cardiovascular Diabetology, vol. 4, p. 14, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Fernandes-Santos, R. E. Carneiro, L. de Souza Mendonca, M. B. Aguila, and C. A. Mandarim-de-Lacerda, “Pan-PPAR agonist beneficial effects in overweight mice fed a high-fat high-sucrose diet,” Nutrition, vol. 25, no. 7-8, pp. 818–827, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Tenenbaum, M. Motro, E. Z. Fisman et al., “Effect of bezafibrate on incidence of type 2 diabetes mellitus in obese patients,” European Heart Journal, vol. 26, no. 19, pp. 2032–2038, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Tenenbaum, E. Z. Fisman, V. Boyko et al., “Attenuation of progression of insulin resistance in patients with coronary artery disease by bezafibrate,” Archives of Internal Medicine, vol. 166, no. 7, pp. 737–741, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Simons, “Angiogenesis, arteriogenesis, and diabetes: paradigm reassessed?” Journal of the American College of Cardiology, vol. 46, no. 5, pp. 835–837, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Simons, “Angiogenesis: where do we stand now?” Circulation, vol. 111, no. 12, pp. 1556–1566, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Biscetti, G. Straface, D. Pitocco, F. Zaccardi, G. Ghirlanda, and A. Flex, “Peroxisome proliferator-activated receptors and angiogenesis,” Nutrition, Metabolism and Cardiovascular Diseases, vol. 19, no. 11, pp. 751–759, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Carmeliet, “Angiogenesis in health and disease,” Nature Medicine, vol. 9, no. 6, pp. 653–660, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. N. Ferrara, “Vascular endothelial growth factor,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 6, pp. 789–791, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. R. S. Kerbel, “Tumor angiogenesis,” New England Journal of Medicine, vol. 358, no. 19, pp. 2039–2049, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. J. P. Cook, “NO and angiogenesis,” Atherosclerosis Supplements, vol. 4, no. 4, pp. 53–60, 2003. View at Google Scholar
  14. C. D. Luque, H. Vargas Robles, E. Romo, A. Rios, and B. Escalante, “The role of nitric oxide in the post-ischemic revascularization process,” Pharmacology and Therapeutics, vol. 112, no. 2, pp. 553–563, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Taniyama, R. Morishita, M. Aoki et al., “Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease,” Gene Therapy, vol. 8, no. 3, pp. 181–189, 2001. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Murohara, T. Asahara, M. Silver et al., “Nitric oxide synthase modulates angiogenesis in response to tissue ischemia,” Journal of Clinical Investigation, vol. 101, no. 11, pp. 2567–2578, 1998. View at Google Scholar · View at Scopus
  17. A. Katayama, Y. Yamamoto, K. Tanaka et al., “Fenofibrate enhances neovascularization in a murine ischemic hindlimb model,” Journal of Cardiovascular Pharmacology, vol. 54, no. 5, pp. 399–404, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Panigrahy, A. Kaipainen, S. Huang et al., “PPARα agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 3, pp. 985–990, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. J. A. Beckman, M. A. Creager, and P. Libby, “Diabetes and atherosclerosis epidemiology, pathophysiology, and management,” Journal of the American Medical Association, vol. 287, no. 19, pp. 2570–2581, 2002. View at Google Scholar · View at Scopus
  20. N. Ferrara, “Vascular endothelial growth factor: molecular and biological aspects,” Current Topics in Microbiology and Immunology, vol. 237, pp. 1–30, 1999. View at Google Scholar · View at Scopus
  21. P. Carmeliet, “Mechanisms of angiogenesis and arteriogenesis,” Nature Medicine, vol. 6, no. 4, pp. 389–395, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Kawasaki, R. S. Smith Jr, C. M. Hsieh, J. Sun, J. Chao, and J. K. Liao, “Activation of the phosphatidylinositol 3-kinase/protein kinase Akt pathway mediates nitric oxide-induced endothelial cell migration and angiogenesis,” Molecular and Cellular Biology, vol. 23, no. 16, pp. 5726–5737, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Murohara, B. Witzenbichler, I. Spyridopoulos et al., “Role of endothelial nitric oxide synthase in endothelial cell migration,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 5, pp. 1156–1161, 1999. View at Google Scholar · View at Scopus
  24. D. Fukumura, T. Gohongi, A. Kadambi et al., “Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 5, pp. 2604–2609, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Pozzi and J. V. Capdevila, “PPARalpha ligands as antitumorigenic and antiangiogenic agents,” PPAR Research, vol. 2008, Article ID 906542, 8 pages, 2008. View at Publisher · View at Google Scholar
  26. D. Bishop-Bailey, “Peroxisome proliferator-activated receptor beta/delta goes vascular,” Circulation Research, vol. 102, no. 2, pp. 146–147, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. R. S. Elkeles, J. R. Diamond, C. Poulter et al., “Cardiovascular outcomes in type 2 diabetes: a double-blind placebo- controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park diabetes cardiovascular disease prevention (SENDCAP) study,” Diabetes Care, vol. 21, no. 4, pp. 641–648, 1998. View at Publisher · View at Google Scholar · View at Scopus
  28. C. G. Ericsson, J. Nilsson, L. Grip, B. Svane, and A. Hamsten, “Effect of bezafibrate treatment over five years on coronary plaques causing 20% to 50% diameter narrowing (The Bezafibrate Coronary Atherosclerosis Intervention Trial [BECAIT]),” American Journal of Cardiology, vol. 80, no. 9, pp. 1125–1129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Biscetti, E. Gaetani, A. Flex et al., “Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPARgamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism,” Diabetes, vol. 57, no. 5, pp. 1394–1404, 2008. View at Publisher · View at Google Scholar · View at Scopus